My research is mainly focused on developing leading-edge mass spectrometry-based proteomics technologies and applying them to 1) elucidate the molecular mechanisms of cancer progression and metastasis, 2) identify and credential clinically actionable therapeutic targets for precision treatment of lethal cancer, and 3) discover novel biomarkers to select patients and monitor drug response.

• Doctorate: Peking University, 2006

View CV